Article

Promoting adjustment after treatment for cancer

Department of Psychology, University of California, Los Angeles, Los Ángeles, California, United States
Cancer (Impact Factor: 4.9). 12/2005; 104(11 Suppl):2608-13. DOI: 10.1002/cncr.21246
Source: PubMed

ABSTRACT The transition from the period of diagnosis and medical treatment of cancer to survivorship (i.e., the reentry phase) is an understudied phase in the cancer trajectory. The objectives of this report were 1) to illustrate several adaptive tasks of the reentry phase, 2) to provide examples of research on factors that predict positive adjustment during this phase, and 3) to discuss interventions that address the adaptive tasks of early cancer survivorship. Although the pertinent empirical literature is scarce, accounts from cancer survivors, healthcare professionals, and qualitative researchers converge to suggest several themes in adaptive tasks during reentry. Drawing from the authors' work and that of others, the authors have described common expectancies held by many individuals approaching reentry (e.g., "I shouldn't need support"), typical concerns during this phase (e.g., concern over cancer recurrence), and personal and contextual factors that can facilitate and hinder adjustment. Promising psychosocial interventions have been developed for individuals in the reentry period. Continued research will be necessary to characterize this important phase of cancer survivorship.

Full-text

Available from: Julia Rowland, Oct 03, 2014
0 Followers
 · 
65 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This longitudinal study aims to gain more insight in both the changes in personal control due to a breast cancer diagnosis, as well as in the stress-buffering effect of personal control. Personal control and distress were assessed in breast cancer patients not treated with chemotherapy (n=47), breast cancer patients treated with chemotherapy (n=32) and in healthy women (n=58) at 3, 9 and 15 months after diagnosis. Results indicate that personal control was affected only in patients treated with chemotherapy, particularly right after the completion of treatment. Furthermore, the cross-sectional and longitudinal results provide modest support for the stress-buffering potential of control. The findings and future directions of research on the role of personal control in the adjustment to cancer will be discussed.
    Psycho-Oncology 01/2009; 18(1):104-8. DOI:10.1002/pon.1333 · 4.04 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Clinical and anecdotal findings suggest that the completion of cancer treatment may be marked by heightened distress and disrupted adjustment. The present study examined psychological adjustment during the 3 months following treatment among 89 women with stages 0-III breast cancer. Participants completed measures of depression, cancer-related anxiety, cancer concerns, and quality of life at three time points: during treatment, 3 weeks following the end of treatment, and 3 months post-treatment. Post-treatment scores were suggestive of good psychological adjustment among the majority of women. Moreover, distress did not increase following treatment; longitudinal analyses showed no significant changes in depression or recurrence worry, while intrusive thoughts decreased, and quality of life improved. Younger age predicted greater distress across measures. A history of depression or anxiety predicted greater depressive symptomatology, while more extensive treatment predicted greater cancer-related anxiety. Despite the lack of distress endorsed on general depression and anxiety indices, participants reported moderate distress associated with cancer-related concerns, including physical problems, fear of cancer recurrence, and resuming normal life. In sum, while breast cancer survivors demonstrate good adjustment on general distress indices following treatment, some women are at risk for sustained distress. Moreover, significant cancer-related concerns are prevalent and may be important intervention targets.
    British Journal of Cancer 01/2008; 97(12):1625-31. DOI:10.1038/sj.bjc.6604091 · 4.82 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: The way couples deal with stressors is likely to influence their adjustment after breast cancer diagnosis. Based on the systemic-transactional model, this study examined whether the supportive, delegated and negative dyadic coping provided by patients and partners and their common dyadic coping as a couple were associated with change in relationship quality and depressive symptoms over time. Method: Women with breast cancer and their male partners (N = 538 couples) participated in a longitudinal study (Time 1, ≤4 months after surgery; Time 2, 5 months later). Dyadic coping was assessed using the Dyadic Coping Inventory (Bodenmann, 2008). The Center for Epidemiologic Studies-Depression Scale (Radloff, 1977) and the Relationship Ladder (Kuijer, Buunk, De Jong, Ybema, & Sanderman, 2004) measured depressive symptoms and relationship quality, respectively. Results: Negative dyadic coping was adversely associated with both patients' and partners' outcomes. The more patients rated the couple as engaging in common dyadic coping, the higher relationship quality and the fewer depressive symptoms both patients and partners experienced. Patients experienced more depressive symptoms the more delegated coping (i.e., taking over tasks) they provided to the partner. Partners experienced fewer depressive symptoms the more delegated coping they provided to the patient, but more depressive symptoms the more supportive coping the patient provided to them. Conclusion: This study has contributed to disentangling how dyadic coping behaviors influence couples' adjustment. Interventions may focus on reducing negative dyadic coping and strengthening common dyadic coping, and be attentive to the different effects of dyadic coping on patients and partners. (PsycINFO Database Record (c) 2015 APA, all rights reserved).
    Health Psychology 03/2015; 34(5). DOI:10.1037/hea0000218 · 3.95 Impact Factor